Reacción #47418

Ecuación de reacción

triethylamine

(S)-2-[4-(3-bromo-2-fluoro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid

1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-ylamine

benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate

→

(S)-2-[4-(3-bromo-2-fluoro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-yl]-amide

Rendimiento 55.0%

Disolventes

N,N-dimethylformamide

Condiciones de reacción

Tratamiento posterior

1. 1
   workup.STIRRINGThe mixture was stirred at room temperature for 4 h
2. 2
   Otrothe solvents were evaporated
3. 3
   workup.ADDITIONThe residue was treated with ethyl acetate and ammonium chloride solution
4. 4
   Otrothe organic layer separated
5. 5
   LavadoThe organic layer was washed with brine
6. 6
   Secadodried over sodium sulfate
7. 7
   OtroThe solvents were evaporated
8. 8
   Otrothe residue was purified by ISCO flash chromatography (Teledyne Isco RediSep Flash Column 12 g, 10% to 50% ethyl acetate/hexanes) which

Procedimiento

To a solution of (S)-2-[4-(3-bromo-2-fluoro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid (0.250 g, 0.65 mmol) in N,N-dimethylformamide (10 mL) was added 1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-ylamine (prepared as in Example 49, 0.166 g, 0.84 mmol) and benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (0.576 g, 1.30 mmol). The mixture was stirred at 0° C. and triethylamine (0.140 g, 1.37 mmol) was added. The mixture was stirred at room temperature for 4 h and the solvents were evaporated. The residue was treated with ethyl acetate and ammonium chloride solution, and the organic layer separated. The organic layer was washed with brine and dried over sodium sulfate. The solvents were evaporated and the residue was purified by ISCO flash chromatography (Teledyne Isco RediSep Flash Column 12 g, 10% to 50% ethyl acetate/hexanes) which afforded (S)-2-[4-(3-bromo-2-fluoro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl-methyl)-1H-pyrazol-3-yl]-amide (0.200 g, 55%) as a fluffy powder: HR-ES-MS m/z calculated for C25H30BrFN4O5 [M+H]+ 565.1457, observed 565.1457, 1H NMR (300 MHz, DMSO-d6) δ ppm 1.00 0.90 (d, J=6.4 Hz, 3H), 0.94 (d, J=6.4 Hz, 3H), 1.25 (s, 3H), 1.30 (s, 3H), 1.45 (br. s., 1H), 1.50-1.65 (m, 1H), 1.68-1.83 (m, 1H), 3.73 (dd, J=8.5, 5.7 Hz, 1H), 4.00 (dd, J=8.5, 6.3 Hz, 1H), 4.03-4.20 (m, 2H), 4.24 (d, J=18.7 Hz, 1H), 4.29-4.41 (m, 1H), 4.61 (d, J=18.7 Hz, 1H), 4.89 (dd, J=10.9, 4.8 Hz, 1H), 5.00 (s, 1H), 6.44 (d, J=2.1 Hz, 1H), 7.27 (td, J=8.2, 1.4 Hz, 1H), 7.49-7.59 (m, 1H), 7.60 (d, J=2.1 Hz, 1H), 7.63-7.74 (m, 1H), 10.81 (s, 1H).

Fuente